Internal FDA Menaflex Investigation Finds Serious Process Deviations
This article was originally published in The Gray Sheet
Executive Summary
An internal evaluation of FDA's handling of the controversial 510(k) clearance of a knee implant unearthed serious shortcomings in the integrity of the agency's review process, FDA said Sept. 24